Understanding Your Progressive Fibrotic Lung Disease
Your CT scan shows worsening scarring (fibrosis) in your lungs with a pattern called "probable UIP" (usual interstitial pneumonia), which indicates progressive fibrotic interstitial lung disease that requires prompt pulmonary specialist evaluation and likely antifibrotic treatment. 1
What the Key Findings Mean
The Fibrotic Changes (Lung Scarring)
Your scan demonstrates several concerning features that define progressive fibrotic lung disease:
Peripheral subpleural reticulations: These are web-like patterns of scarring predominantly at the outer edges of your lungs, particularly at the bases (bottom portions). This is a hallmark of UIP pattern. 1
Traction bronchiectasis: Your airways are being pulled open and distorted by the surrounding scar tissue—this is one of the most important prognostic indicators in fibrotic lung disease and confirms that the scarring is significant. 2
Architectural distortion: The normal lung structure is being disrupted by the fibrosis, with irregular, tortuous blood vessels and airways.
Basilar predominance: The scarring is worse at the lung bases, which is typical for UIP pattern.
No honeycombing yet: Importantly, you don't have honeycombing (the most advanced stage of scarring), which means this hasn't progressed to the most severe radiologic UIP pattern. 1
What "Probable UIP Pattern" Means
The "probable UIP" classification is significant. According to the most recent 2025 ATS guidelines, this pattern—when showing progression as yours does—meets criteria for established interstitial lung disease requiring treatment consideration. 1
The probable UIP pattern has important prognostic implications: Research shows that while probable UIP generally has somewhat better outcomes than definite UIP pattern (with honeycombing), when it progresses to a final diagnosis of IPF or progressive pulmonary fibrosis, the CT pattern distinction becomes less relevant—what matters is the progression itself. 3, 4
The Progression Component
The critical finding is that your disease has progressed compared to your prior scan. Progressive fibrotic abnormality on serial chest CT is one of the defining criteria for established ILD that warrants treatment. 1 This progression, combined with the probable UIP pattern, strongly suggests you need antifibrotic therapy evaluation. 5
Additional Concerning Findings
Pulmonary Hypertension
The dilated central pulmonary arteries indicate pulmonary hypertension—elevated pressure in the lung blood vessels. This is a common and serious complication of advanced fibrotic lung disease that can significantly impact your heart function and exercise capacity. This finding suggests your lung disease is already affecting your cardiovascular system.
Pleural Thickening
The scattered pleural thickening (thickening of the lung lining) can be associated with the underlying fibrotic process.
What This Means for Your Care
Immediate Next Steps
Pulmonary function testing: You need comprehensive testing including FVC (forced vital capacity), TLC (total lung capacity), and DLCO (diffusion capacity) to quantify the functional impact and establish baseline for monitoring. 1
Determine the underlying cause: The differential diagnosis for probable UIP pattern includes:
- Idiopathic pulmonary fibrosis (IPF)
- Connective tissue disease-associated ILD (especially rheumatoid arthritis, systemic sclerosis)
- Chronic hypersensitivity pneumonitis
- Drug-induced fibrosis
You need thorough evaluation including autoimmune serologies, detailed exposure history (birds, mold, medications), and possibly rheumatology consultation. 5, 6
Multidisciplinary discussion: Your case should be reviewed by a team including pulmonologists, radiologists, and potentially pathologists to determine if this represents IPF or another progressive fibrotic ILD. 5, 7
Treatment Implications
If diagnosed with IPF or progressive pulmonary fibrosis, antifibrotic medications (nintedanib or pirfenidone) are indicated to slow disease progression. 5 These medications have been shown to reduce the rate of lung function decline and are now recommended for various progressive fibrotic ILDs beyond just IPF.
Monitoring Strategy
Given the documented progression, you need:
- Serial pulmonary function tests every 3-6 months
- Follow-up chest CT at intervals determined by your pulmonologist (typically 6-12 months for stable disease, sooner if symptoms worsen) 5
- Screening for complications including lung cancer (you're at increased risk) and monitoring of the pulmonary hypertension
Critical Pitfalls to Avoid
Don't delay specialist referral. Progressive fibrotic ILD has significant mortality risk, and early antifibrotic treatment initiation improves outcomes. The presence of traction bronchiectasis and documented progression are red flags requiring urgent action. 2
Don't assume this is "just aging lungs." The probable UIP pattern with progression represents established disease requiring treatment, not incidental age-related changes. 1
Evaluate for lung transplant candidacy early if you're otherwise healthy, as advanced fibrotic lung disease may progress to respiratory failure. 5